Rise and shine, everyone. Another day is on the way. And we predict this will prove to be as busy as ever. So please join us for a cup of needed stimulation - our special flavor today is Southern Pecan - as we get ready for those meetings and deadlines. No doubt, you can relate. Meanwhile, here are some tidbits to help you along. Have a good one and do stay in touch...
Merck Beats Vertex To Hepatitis C Filing (TheStreet)
Merck And Ranbaxy End Development Deal (Economic Times)
Biogen Names New Heads For R&D, Corporate Development (Bloomberg News)
Danish Biotech Symphogen Raises A Record $131 Million (Reuters)
Basilea Becomes Takeover Speculation (Bloomberg News)
Pfizer And Seattle Genetics Reach Antibody Deal (Reuters)
Roche Asks Employees To Act As Social Media Scouts (InPharm)
University Supports Stanford In Patent Fight Against Roche (Daily Camera)
ChemRx Closes Facility And Eliminates 50 Jobs (PoconoNews)
Coffee pix thx to chichcacha flickr creative commons
3 Comments
I think the Daily Camera article headline should read "patent" instead of "patient" (Darn, I love a good patient fight!).
To all fellow readers on the Island: "Feliz dia de los Tres Reyes!"
(Of course, you are off today but maybe you will see this on Friday!)
The piece on Riche and social media has a very dated timestamp - any idea how current this is? It display as:
Published on 17/08/10 at 09:31am